Public Policy Briefing

BioNJ’s monthly Public Policy Briefings keep BioNJ’s Community up to date on the latest developments at both the State and Federal level. Email RBromberg@BioNJ.org if you wish to receive BioNJ’s Public Policy Briefings.

Public Policy Briefing: the Reauthorization of the Prescription Drug User Fee Act

Public Policy Briefing: BioNJ Goes to Washington for BIO Legislative Fly-In April 4-5

Public Policy Briefing: Celebrating Life Sciences Month on the Policy Front

Public Policy Briefing: Uncertainty is the New Certainty in Washington

Public Policy Briefing: Expect the Unexpected in 2017

Public Policy Briefing: 21st Century Cures 

Public Policy Briefing: BioNJ’s Fall 2016 Legislative Agenda 

Public Policy Briefing: Sustaining & Strengthening NJ’s Life Sciences Ecosystem 

Public Policy Briefing: Increased Clinical Trials in NJ Good for Patients & the Economy

Public Policy Briefing: It’s Time (Again) for a New Jersey Biotechnology Task Force

Public Policy Briefing: BIO Federal Legislative Fly-In

Public Policy Briefing: Rare Disease Day Events Highlight Need for Cures

Public Policy Briefing: New Jersey’s Angel Investor Tax Credits

Public Policy Briefing: The Fall 2015 Legislative Outlook